Fate Therapeutics (FATE) shares rise 5% in recent Friday trading after HC Wainwright upgraded the stock to buy from neutral with a price target of $5.
Inraday volume topped 1.12 million shares, compared with the daily average of almost 2.1 million.
Price: 1.36, Change: +0.07, Percent Change: +5.04